Success Stories: EB-1A Approved for a Research Associate in Michigan in the Field of Pharmaceutical Sciences
Client’s Testimonial:
Thanks a lot for your help to get my EB-1A approval. I am really very much happy to refer you to some of my friends.
General Field: Pharmaceutical Sciences
Position at the Time of Case Filing: Research Associate
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Michigan
Approval Notice Date: August 4, 2014
Processing Time: 6 Months, 12 Days
Case Summary:
In this case, the client that we had the pleasure of working with was a Research Associatein Michiganin the field of Pharmaceutical Sciences. He conducts his research in the highly specialized areas of comprehensive investigation of the mechanisms of variable drug responses and the complexities of human genetic diseases, specifically in terms of the ear and hearing loss. His work had resulted in 16 peer-reviewed scientific articles, 2 book chapters, 2 patents, and numerous presentations at national and international conferences. At the time that his case was filed, his publications had been cited at least 97 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also conducted 23 manuscript reviews for at least 5 distinctive, internationally circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “Research for treating fungal infections is especially important as they become more and more common among the most vulnerable of populations. The United States should put forth the utmost effort to support the continued studies of [client], as the country’s healthcare is at stake. He has made great headway in the treatment of fungal infections, and this type of expertise will save the United States lives and money from extraneous healthcare costs.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmaceutical Sciences, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 6 months and 12 days.

